top of page

Drug-Prices Investigation Focused on Middlemen Opens in Congress

House Republicans have launched an investigation into the companies that manage drug benefits, dialing up the scrutiny of the middlemen who play an important role in how much medicines cost.

Read the full story >

1 view
bottom of page